BCM
DGX icon

Becker Capital Management’s Quest Diagnostics DGX Stock Holding History

Becker Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3M Buy
62,849
+683
+1% +$133K 0.36% 75
2025
Q4 		$10.8M Sell
62,166
-1,951
-3% -$355K 0.31% 78
2025
Q3 		$12.2M Sell
64,117
-1,135
-2% -$201K 0.36% 70
2025
Q2 		$11.7M Sell
65,252
-954
-1% -$166K 0.37% 74
2025
Q1 		$11.2M Sell
66,206
-7,483
-10% -$1.23M 0.37% 78
2024
Q4 		$11.1M Sell
73,689
-12,039
-14% -$1.87M 0.36% 73
2024
Q3 		$13.3M Sell
85,728
-739
-0.9% -$110K 0.43% 68
2024
Q2 		$11.8M Sell
86,467
-7,362
-8% -$1.01M 0.41% 74
2024
Q1 		$12.5M Sell
93,829
-31,275
-25% -$4.06M 0.43% 72
2023
Q4 		$17.2M Sell
125,104
-1,248
-1% -$164K 0.62% 58
2023
Q3 		$15.4M Buy
126,352
+16
+0% +$2.13K 0.61% 61
2023
Q2 		$17.8M Sell
126,336
-6,076
-5% -$838K 0.67% 59
2023
Q1 		$18.7M Sell
132,412
-1,544
-1% -$221K 0.74% 55
2022
Q4 		$21M Sell
133,956
-3,762
-3% -$541K 0.98% 41
2022
Q3 		$16.9M Sell
137,718
-4,805
-3% -$633K 0.89% 46
2022
Q2 		$19M Buy
142,523
+9,494
+7% +$1.29M 0.91% 45
2022
Q1 		$18.2M Buy
133,029
+15,085
+13% +$2.1M 0.73% 56
2021
Q4 		$20.4M Sell
117,944
-3,710
-3% -$564K 0.81% 53
2021
Q3 		$17.7M Buy
121,654
+7,737
+7% +$1.13M 0.74% 57
2021
Q2 		$15M Sell
113,917
-546
-0.5% -$71.5K 0.64% 60
2021
Q1 		$14.7M Buy
114,463
+879
+0.8% +$108K 0.66% 57
2020
Q4 		$13.5M Sell
113,584
-9,670
-8% -$1.18M 0.67% 57
2020
Q3 		$14.1M Sell
123,254
-2,980
-2% -$352K 0.78% 51
2020
Q2 		$14.4M Sell
126,234
-13,834
-10% -$1.47M 0.81% 56
2020
Q1 		$11.2M Sell
140,068
-58,547
-29% -$6.06M 0.68% 56
2019
Q4 		$21.2M Buy
+198,615
New +$20.7M 0.75% 57
2017
Q2 		– Sell
-6,300
Closed -$619K – 137
2017
Q1 		$619K Hold
6,300
– – 0.02% 96
2016
Q4 		$579K Hold
6,300
– – 0.02% 102
2016
Q3 		$533K Buy
+6,300
New +$529K 0.02% 102

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Becker Capital Management's DGX Position: Q1 2026 in Review

Becker Capital Management increased its Quest Diagnostics (DGX) stake by 1.1% in Q1 2026, buying an estimated $133K and bringing the position to 62,849 shares worth $12.3M. The position accounts for 0.36% of the portfolio, ranked #75.

Becker Capital Management first reported a position in DGX in Q3 2016 and has held it in 29 quarters since. The position peaked at $21.2M in Q4 2019. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Becker Capital Management held 62,849 shares of Quest Diagnostics worth $12.3M as of Q1 2026.
  • Becker Capital Management bought 683 Quest Diagnostics shares in Q1 2026, an estimated $133K.
  • Quest Diagnostics made up 0.36% of Becker Capital Management's portfolio in Q1 2026, its #75 holding.
  • Becker Capital Management first reported a position in Quest Diagnostics in Q3 2016 and has held it in 29 quarters since.
  • Becker Capital Management's Quest Diagnostics position peaked at $21.2M in Q4 2019.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Becker Capital Management's 13F filing for Q1 2026, filed 11 May 2026.